Detalhe da pesquisa
1.
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma.
Haematologica
; 106(4): 978-986, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327504
2.
Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel.
Cancer Med
; 10(6): 1936-1943, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641257
3.
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma.
Blood Adv
; 4(14): 3268-3276, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702097